Genetic	O
heterogeneity	O
and	O
penetrance	O
analysis	O
of	O
the	O
BRCA1	O
and	O
BRCA2	O
genes	O
in	O
breast	B
cancer	I
families	O
.	O
	
METHODS	O
DNA	O
samples	O
from	O
500	O
unrelated	O
Jews	O
of	O
European	O
or	O
non	O
-	O
European	O
origin	O
,	O
with	O
or	O
without	O
a	O
personal	O
and	O
/	O
or	O
family	O
history	O
of	O
neoplasia	B
,	O
were	O
examined	O
for	O
the	O
I1307K	O
variant	O
by	O
the	O
allele	O
-	O
specific	O
oligonucleotide	O
(	O
ASO	O
)	O
method	O
.	O
	
Molecular	O
heterogeneity	O
in	O
mucopolysaccharidosis	B
IVA	I
in	O
Australia	O
and	O
Northern	O
Ireland	O
:	O
nine	O
novel	O
mutations	O
including	O
T312S	O
,	O
a	O
common	O
allele	O
that	O
confers	O
a	O
mild	O
phenotype	O
.	O
	
I1307K	O
APC	O
and	O
hMLH1	O
mutations	O
in	O
a	O
non	O
-	O
Jewish	O
family	O
with	O
hereditary	B
non	I
-	I
polyposis	I
colorectal	I
cancer	I
.	O
	
BRCA1	O
mutations	O
are	O
rare	O
in	O
sporadic	B
cancers	I
,	O
but	O
loss	O
of	O
BRCA1	O
resulting	O
from	O
reduced	O
expression	O
or	O
incorrect	O
subcellular	O
localization	O
is	O
postulated	O
to	O
be	O
important	O
in	O
non	B
-	I
familial	I
breast	I
and	I
ovarian	I
cancers	I
.	O
	
The	O
185delAG	O
mutation	O
in	O
BRCA1	O
is	O
detected	O
in	O
Ashkenazi	O
Jews	O
both	O
in	O
familial	B
breast	I
and	I
ovarian	I
cancer	I
and	O
in	O
the	O
general	O
population	O
.	O
	
Mutations	O
of	O
the	O
human	O
PAX6	O
gene	O
underlie	O
aniridia	B
(	O
congenital	B
absence	I
of	I
the	I
iris	I
)	O
,	O
a	O
rare	O
dominant	O
malformation	B
of	I
the	I
eye	I
.	O
	
The	O
hemochromatosis	B
845	O
G	O
-	O
-	O
>	O
A	O
and	O
187	O
C	O
-	O
-	O
>	O
G	O
mutations	O
:	O
prevalence	O
in	O
non	O
-	O
Caucasian	O
populations	O
.	O
	
We	O
conclude	O
that	O
these	O
mice	O
very	O
closely	O
mimic	O
severe	O
human	O
von	B
Willebrand	I
disease	I
and	O
will	O
be	O
very	O
useful	O
for	O
investigating	O
the	O
role	O
of	O
vWf	O
in	O
normal	O
physiology	O
and	O
in	O
disease	O
models	O
.	O
.	O
	
However	O
,	O
genotype	O
-	O
phenotype	O
analysis	O
inthe	O
group	O
of	O
CD	B
families	O
revealed	O
two	O
possible	O
associations	O
worthy	O
of	O
follow	O
-	O
up	O
in	O
independent	O
analyses	O
.	O
	
While	O
a	O
few	O
cases	O
of	O
isolated	O
ACTH	B
deficiency	I
have	O
been	O
reported	O
(	O
OMIM	O
201400	O
)	O
,	O
an	O
inherited	O
POMC	O
defect	O
has	O
not	O
been	O
described	O
so	O
far	O
.	O
	
We	O
review	O
the	O
sex	O
related	O
effects	O
on	O
transmission	O
of	O
congenital	B
DM	I
.	O
	
Hereditary	B
coproporphyria	I
(	O
HC	B
)	O
is	O
an	O
acute	O
hepatic	B
porphyria	I
with	O
autosomal	O
dominant	O
inheritance	O
caused	O
by	O
deficient	B
activity	I
of	I
coproporphyrinogen	I
III	I
oxidase	I
(	O
CPO	O
)	O
.	O
	
In	O
a	O
family	O
with	O
three	O
siblings	O
,	O
one	O
developed	O
classical	O
late	O
infantile	O
metachromatic	B
leukodystrophy	I
(	O
MLD	B
)	O
,	O
fatal	O
at	O
age	O
5	O
years	O
,	O
with	O
deficient	O
arylsulfatase	O
A	O
(	O
ARSA	O
)	O
activity	O
and	O
increased	O
galactosylsulfatide	O
(	O
GS	O
)	O
excretion	O
.	O
	
In	O
combination	O
with	O
molecular	O
genetic	O
analyses	O
,	O
this	O
test	O
may	O
be	O
of	O
value	O
in	O
studies	O
of	O
familial	B
and	I
sporadic	I
cancers	I
aimed	O
at	O
determination	O
of	O
the	O
potential	O
involvement	O
of	O
ATM	O
mutations	O
in	O
tumor	B
risk	O
or	O
development	O
.	O
.	O
	
Complete	O
analysis	O
of	O
the	O
dystrophin	O
gene	O
was	O
performed	O
to	O
define	O
the	O
localization	O
of	O
deletions	O
and	O
duplications	O
in	O
relation	O
to	O
the	O
different	O
DMD	B
promoters	O
.	O
	
Human	B
complement	I
factor	I
H	I
deficiency	I
associated	O
with	O
hemolytic	B
uremic	I
syndrome	I
.	O
	
In	O
the	O
present	O
study	O
,	O
the	O
classification	O
of	O
105	O
PAH	O
mutations	O
may	O
allow	O
the	O
prediction	O
of	O
the	O
biochemical	O
phenotype	O
in	O
>	O
10	O
,	O
000	O
genotypes	O
,	O
which	O
may	O
be	O
useful	O
for	O
the	O
management	O
of	O
hyperphenylalaninemia	B
in	O
newborns	O
.	O
	
It	O
is	O
therefore	O
concluded	O
that	O
the	O
R496H	O
mutation	O
of	O
ARSA	O
does	O
not	O
negatively	O
influence	O
the	O
activity	O
of	O
ARSA	O
and	O
is	O
not	O
a	O
cause	O
of	O
MLD	B
	
The	O
mutation	O
is	O
in	O
an	O
area	O
of	O
the	O
gene	O
that	O
encodes	O
the	O
protein	O
-	O
binding	O
region	O
known	O
as	O
the	O
pocket	O
region	O
and	O
has	O
been	O
detected	O
in	O
other	O
cases	O
of	O
retinoblastoma	B
.	O
.	O
	
We	O
report	O
the	O
spectrum	O
of	O
59	O
ATM	O
mutations	O
observed	O
in	O
ataxia	B
-	I
telangiectasia	I
(	O
A	B
-	I
T	I
)	O
patients	O
in	O
the	O
British	O
Isles	O
.	O
	
Recent	O
studies	O
demonstrated	O
the	O
existence	O
of	O
a	O
genetically	O
distinct	O
,	O
usually	O
lethal	O
form	O
of	O
the	O
Schwartz	B
-	I
Jampel	I
syndrome	I
(	O
SJS	B
)	O
of	O
myotonia	B
and	O
skeletal	B
dysplasia	I
,	O
which	O
we	O
called	O
SJS	B
type	I
2	I
.	O
	
Southern	O
blot	O
and	O
PCR	O
analyses	O
have	O
indicated	O
that	O
the	O
individual	O
with	O
anhaptoglobinemia	B
was	O
homozygous	O
for	O
the	O
gene	O
deletion	O
and	O
that	O
the	O
gene	O
deletion	O
was	O
included	O
at	O
least	O
from	O
the	O
promoter	O
region	O
of	O
Hp	O
to	O
Hpr	O
alpha	O
but	O
not	O
to	O
Hpr	O
beta	O
(	O
Hpdel	O
)	O
.	O
	
The	O
spectrum	O
of	O
PAX6	O
mutations	O
in	O
aniridia	B
patients	O
is	O
highly	O
biased	O
,	O
with	O
92	O
%	O
of	O
all	O
reported	O
mutations	O
leading	O
to	O
premature	O
truncation	O
of	O
the	O
protein	O
(	O
nonsense	O
,	O
splicing	O
,	O
insertions	O
and	O
deletions	O
)	O
and	O
just	O
2	O
%	O
leading	O
to	O
substitution	O
of	O
one	O
amino	O
acid	O
by	O
another	O
(	O
missense	O
)	O
.	O
	
BRCA1	O
allelic	O
patterns	O
were	O
determined	O
for	O
four	O
of	O
these	O
individuals	O
and	O
for	O
12	O
additional	O
non	O
-	O
Ashkenazi	O
185delAG	O
mutation	O
carriers	O
who	O
had	O
breast	B
/	I
ovarian	I
cancer	I
.	O
	
Friedreich	B
ataxia	I
is	O
usually	O
caused	O
by	O
an	O
expansion	O
of	O
a	O
GAA	O
trinucleotide	O
repeat	O
in	O
intron	O
1	O
of	O
the	O
FRDA	B
gene	O
.	O
	
Variability	O
in	O
the	O
number	O
of	O
colorectal	B
adenomas	I
was	O
most	O
apparent	O
in	O
individuals	O
with	O
mutations	O
in	O
region	O
1	O
,	O
and	O
upper	O
-	O
gastrointestinal	O
manifestations	O
were	O
more	O
severe	O
in	O
them	O
.	O
	
Maternal	B
disomy	I
and	O
Prader	B
-	I
Willi	I
syndrome	I
consistent	O
with	O
gamete	O
complementation	O
in	O
a	O
case	O
of	O
familial	O
translocation	O
(	O
3	O
;	O
15	O
)	O
(	O
p25	O
;	O
q11	O
.	O
2	O
)	O
.	O
	
Affected	O
individuals	O
are	O
not	O
symptomatic	O
at	O
birth	O
,	O
but	O
usually	O
develop	O
diabetes	B
insipidus	I
at	O
1	O
-	O
6	O
yr	O
of	O
age	O
.	O
	
To	O
determine	O
the	O
frequency	O
and	O
nature	O
of	O
constitutional	O
RB1	O
-	O
gene	O
mutations	O
in	O
patients	O
with	O
isolated	O
unilateral	B
retinoblastoma	I
,	O
we	O
analyzed	O
DNA	O
from	O
peripheral	O
blood	O
and	O
from	O
tumor	B
tissue	O
.	O
	
Genetic	O
basis	O
and	O
molecular	O
mechanism	O
for	O
idiopathic	B
ventricular	I
fibrillation	I
.	O
	
3	O
and	O
encodes	O
a	O
403	O
amino	O
acid	O
dual	O
specificity	O
phosphatase	O
(	O
protein	O
tyrosine	O
phosphatase	O
;	O
PTPase	O
)	O
,	O
was	O
shown	O
recently	O
to	O
play	O
a	O
broad	O
role	O
in	O
human	O
malignancy	B
.	O
	
To	O
date	O
,	O
our	O
detection	O
rate	O
for	O
TWIST	O
or	O
FGFR	O
mutations	O
is	O
68	O
%	O
in	O
our	O
Saethre	B
-	I
Chotzen	I
syndrome	I
patients	O
,	O
including	O
our	O
five	O
patients	O
elsewhere	O
reported	O
with	O
TWIST	O
mutations	O
.	O
	
We	O
studied	O
the	O
molecular	O
basis	O
of	O
C9	B
deficiency	I
in	O
four	O
Japanese	O
C9	B
-	I
deficient	I
patients	O
who	O
had	O
suffered	O
from	O
meningococcal	B
meningitis	I
.	O
	
For	O
39	O
randomly	O
selected	O
tumors	B
,	O
SSCP	O
,	O
hetero	O
-	O
duplex	O
analysis	O
,	O
sequencing	O
,	O
and	O
Southern	O
blot	O
analysis	O
were	O
used	O
to	O
identify	O
mutations	O
.	O
	
Detection	O
of	O
heterozygous	O
carriers	O
of	O
the	O
ataxia	B
-	I
telangiectasia	I
(	O
ATM	O
)	O
gene	O
by	O
G2	O
phase	O
chromosomal	O
radiosensitivity	O
of	O
peripheral	O
blood	O
lymphocytes	O
.	O
	
A	O
number	O
of	O
ARSA	O
gene	O
mutations	O
responsible	O
for	O
MLD	B
have	O
been	O
identified	O
.	O
	
We	O
report	O
,	O
in	O
two	O
A	B
-	I
T	I
families	O
,	O
an	O
ATM	O
mutation	O
(	O
7271T	O
-	O
-	O
>	O
G	O
)	O
that	O
may	O
be	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
breast	B
cancer	I
in	O
both	O
homozygotes	O
and	O
heterozygotes	O
(	O
relative	O
risk	O
12	O
.	O
7	O
;	O
P	O
=	O
.	O
0025	O
)	O
,	O
although	O
there	O
is	O
a	O
less	O
severe	O
A	B
-	I
T	I
phenotype	O
in	O
terms	O
of	O
the	O
degree	O
of	O
cerebellar	B
degeneration	I
.	O
	
Five	O
novel	O
germ	O
-	O
line	O
APC	B
mutations	O
were	O
identified	O
in	O
seven	O
kindreds	O
.	O
	
Genomic	O
sequencing	O
of	O
a	O
BAC	O
clone	O
H	O
_	O
RG364P16	O
revealed	O
the	O
presence	O
of	O
another	O
,	O
highly	O
homologous	O
gene	O
3	O
of	O
the	O
CLD	B
gene	O
,	O
with	O
a	O
similar	O
genomic	O
structure	O
,	O
recently	O
identified	O
as	O
the	O
Pendred	B
syndrome	I
gene	O
(	O
PDS	B
)	O
.	O
.	O
	
Germline	O
PTEN	O
mutations	O
were	O
identified	O
in	O
four	O
of	O
seven	O
(	O
57	O
%	O
)	O
BZS	B
families	O
studied	O
.	O
	
These	O
results	O
provide	O
a	O
new	O
insight	O
into	O
the	O
role	O
of	O
mutant	O
PAX6	O
in	O
causing	O
aniridia	B
.	O
.	O
	
Mutations	O
were	O
located	O
in	O
three	O
different	O
regions	O
of	O
the	O
APC	B
gene	O
(	O
1	O
)	O
at	O
the	O
5	O
end	O
spanning	O
exons	O
4	O
and	O
5	O
,	O
(	O
2	O
)	O
within	O
exon	O
9	O
,	O
and	O
(	O
3	O
)	O
at	O
the	O
3	O
distal	O
end	O
of	O
the	O
gene	O
.	O
	
However	O
,	O
these	O
observations	O
would	O
need	O
to	O
be	O
confirmed	O
by	O
studying	O
a	O
larger	O
number	O
of	O
CD	B
families	O
.	O
	
One	O
male	O
and	O
two	O
female	O
IDMS	B
patients	O
with	O
WT1	O
mutations	O
underwent	O
normal	O
puberty	O
.	O
	
Clinical	O
manifestations	O
of	O
the	O
disease	O
are	O
characterized	O
by	O
acute	O
attacks	O
of	O
neurological	B
dysfunction	I
often	O
precipitated	O
by	O
drugs	O
,	O
fasting	O
,	O
cyclical	O
hormonal	O
changes	O
,	O
or	O
infectious	B
diseases	I
.	O
	
von	B
Willebrand	I
factor	I
(	I
vWf	I
)	I
deficiency	I
causes	O
severe	O
von	B
Willebrand	I
disease	I
in	O
humans	O
.	O
	
These	O
results	O
show	O
that	O
the	O
G2	O
-	O
phase	O
chromosomal	O
radiosensitivity	O
assay	O
can	O
be	O
used	O
for	O
the	O
detection	O
of	O
A	B
-	I
T	I
heterozygotes	O
.	O
	
Direct	O
sequencing	O
of	O
amplified	O
C9	O
cDNA	O
and	O
DNA	O
revealed	O
a	O
nonsense	O
substitution	O
(	O
CGA	O
-	O
-	O
>	O
TGA	O
)	O
at	O
codon	O
95	O
in	O
exon	O
4	O
in	O
the	O
four	O
C9	B
-	I
deficient	I
individuals	O
.	O
	
In	O
addition	O
,	O
PTEN	O
was	O
identified	O
as	O
the	O
susceptibility	O
gene	O
for	O
two	O
hamartoma	B
syndromes	I
Cowden	B
disease	I
(	O
CD	B
;	O
MIM	O
158350	O
)	O
and	O
Bannayan	B
-	I
Zonana	I
(	I
BZS	I
)	I
or	I
Ruvalcaba	I
-	I
Riley	I
-	I
Smith	I
syndrome	I
(	O
MIM	O
153480	O
)	O
.	O
	
This	O
distribution	O
of	O
emerin	O
was	O
similar	O
to	O
that	O
of	O
lamin	O
A	O
,	O
a	O
candidate	O
gene	O
for	O
an	O
autosomal	O
form	O
of	O
EDMD	B
.	O
	
Patients	O
with	O
generalized	O
atrophic	B
benign	I
epidermolysis	I
bullosa	I
often	O
show	O
decreased	O
expression	O
of	O
type	O
XVII	O
collagen	O
,	O
a	O
transmembrane	O
hemidesmosomal	O
protein	O
encoded	O
by	O
COL17A1	O
.	O
	
The	O
genetic	O
locus	O
of	O
the	O
disease	O
is	O
the	O
AVP	O
-	O
neurophysin	O
II	O
(	O
NPII	O
)	O
gene	O
,	O
and	O
mutations	O
that	O
cause	O
ADNDI	B
have	O
been	O
found	O
in	O
both	O
the	O
signal	O
peptide	O
of	O
the	O
prepro	O
-	O
AVP	O
-	O
NPII	O
precursor	O
and	O
within	O
NPII	O
itself	O
.	O
	
Identification	O
of	O
a	O
novel	O
mutation	O
of	O
the	O
CPO	O
gene	O
in	O
a	O
Japanese	O
hereditary	B
coproporphyria	I
family	O
.	O
	
Clinical	O
recognition	O
of	O
VLCAD	B
deficiency	I
is	O
important	O
because	O
it	O
is	O
one	O
of	O
the	O
few	O
directly	O
treatable	O
causes	O
of	O
cardiomyopathy	B
in	O
children	O
.	O
.	O
	
In	O
order	O
to	O
further	O
characterize	O
the	O
dynamics	O
of	O
DM	B
CTG	O
repeat	O
somatic	O
instability	O
,	O
we	O
have	O
studied	O
repeat	O
length	O
changes	O
over	O
time	O
in	O
111	O
myotonic	B
dystrophy	I
patients	O
with	O
varying	O
clinical	O
severity	O
and	O
CTG	O
repeat	O
size	O
over	O
time	O
intervals	O
of	O
1	O
-	O
7	O
years	O
.	O
	
HLA	O
-	O
B27	O
accounts	O
for	O
a	O
minority	O
of	O
the	O
overall	O
genetic	O
susceptibility	O
to	O
AS	B
.	O
	
In	O
2	O
patients	O
without	O
a	O
detectable	O
mutation	O
in	O
peripheral	O
blood	O
,	O
mosaicism	O
was	O
suggested	O
because	O
1	O
of	O
the	O
patients	O
showed	O
multifocal	O
tumors	B
and	O
the	O
other	O
later	O
developed	O
bilateral	B
retinoblastoma	I
.	O
	
We	O
report	O
a	O
rare	O
case	O
of	O
paternally	O
transmitted	O
congenital	B
myotonic	I
dystrophy	I
(	O
DM	B
)	O
.	O
	
Our	O
results	O
support	O
the	O
hypothesis	O
that	O
the	O
under	O
-	O
representation	O
of	O
missense	O
mutations	O
is	O
caused	O
by	O
ascertainment	O
bias	O
and	O
suggest	O
that	O
a	O
substantial	O
burden	O
of	O
PAX6	B
-	I
related	I
disease	I
remains	O
to	O
be	O
uncovered	O
.	O
.	O
	
Hereditary	B
coproporphyria	I
(	O
HCP	B
)	O
is	O
an	O
autosomal	B
dominant	I
disease	I
characterized	O
by	O
a	O
deficiency	B
of	I
coproporphyrinogen	I
oxidase	I
(	O
CPO	O
)	O
caused	O
by	O
a	O
mutation	O
in	O
the	O
CPO	O
gene	O
.	O
	
vWf	B
-	I
deficient	I
mice	O
appeared	O
normal	O
at	O
birth	O
;	O
they	O
were	O
viable	O
and	O
fertile	O
.	O
	
Germline	O
mutations	O
in	O
the	O
p16	O
and	O
CDK4	O
genes	O
have	O
been	O
reported	O
in	O
a	O
subset	O
of	O
melanoma	B
pedigrees	O
,	O
but	O
their	O
prevalence	O
is	O
not	O
well	O
known	O
.	O
	
Our	O
data	O
suggest	O
that	O
the	O
C	O
to	O
A	O
mutation	O
at	O
the	O
penultimate	O
nucleotide	O
of	O
exon	O
6	O
of	O
the	O
CYP27	O
gene	O
not	O
only	O
causes	O
the	O
deficiency	B
in	I
the	I
sterol	I
27	I
-	I
hydroxylase	I
activity	I
,	O
but	O
also	O
partially	O
leads	O
to	O
alternative	O
pre	O
-	O
mRNA	O
splicing	O
of	O
the	O
gene	O
.	O
	
We	O
have	O
now	O
identified	O
a	O
missense	O
mutation	O
,	O
a	O
splice	O
-	O
donor	O
mutation	O
,	O
and	O
a	O
frameshift	O
mutation	O
in	O
the	O
coding	O
region	O
of	O
SCN5A	O
in	O
three	O
IVF	B
families	O
.	O
	
Growth	B
retardation	I
of	O
the	O
Smad4	O
-	O
deficient	O
embryos	O
results	O
from	O
reduced	O
cell	O
proliferation	O
rather	O
than	O
increased	O
apoptosis	O
.	O
	
Fluorescent	O
in	O
situ	O
hybridization	O
analysis	O
demonstrated	O
that	O
the	O
PWS	B
critical	O
region	O
resided	O
on	O
the	O
derivative	O
chromosome	O
3	O
and	O
that	O
there	O
was	O
no	O
deletion	O
of	O
the	O
PWS	B
region	O
on	O
the	O
normal	O
pair	O
of	O
15s	O
present	O
in	O
J	O
.	O
	
Although	O
hemochromatosis	B
is	O
common	O
in	O
Caucasians	O
,	O
affecting	O
>	O
=	O
1	O
/	O
300	O
individuals	O
of	O
northern	O
European	O
origin	O
,	O
it	O
has	O
not	O
been	O
recognized	O
in	O
other	O
populations	O
.	O
	
The	O
RB1	O
gene	O
mutation	O
in	O
a	O
child	O
with	O
ectopic	B
intracranial	I
retinoblastoma	I
.	O
	
Down	O
-	O
regulation	O
of	O
transmembrane	O
carbonic	O
anhydrases	O
in	O
renal	B
cell	I
carcinoma	I
cell	O
lines	O
by	O
wild	O
-	O
type	O
von	B
Hippel	I
-	I
Lindau	I
transgenes	O
.	O
	
We	O
assessed	O
the	O
I1307K	O
prevalence	O
in	O
Israeli	O
Jews	O
of	O
differing	O
ethnic	O
origin	O
and	O
risk	O
for	O
colorectal	B
cancer	I
.	O
	
Studies	O
on	O
meiotic	O
drive	O
in	O
DM	B
have	O
shown	O
increased	O
transmission	O
of	O
the	O
larger	O
allele	O
at	O
the	O
DM	B
locus	O
in	O
non	O
-	O
DM	O
heterozygotes	O
for	O
CTGn	O
.	O
	
In	O
SCA2	B
,	O
saccade	O
velocity	O
was	O
markedly	O
decreased	O
.	O
	
Attenuated	B
adenomatous	I
polyposis	I
coli	I
patients	O
have	O
""""	O
multiple	O
""""	O
colorectal	B
adenomas	I
(	O
typically	O
fewer	O
than	O
100	O
)	O
without	O
the	O
florid	O
phenotype	O
of	O
classical	O
FAP	B
.	O
	
This	O
study	O
provides	O
further	O
evidence	O
that	O
the	O
DM	B
expansion	O
tends	O
to	O
be	O
transmitted	O
preferentially	O
.	O
	
In	O
this	O
study	O
,	O
direct	O
mutation	O
analysis	O
of	O
the	O
APC	B
gene	O
was	O
performed	O
to	O
determine	O
genotype	O
-	O
phenotype	O
correlations	O
for	O
nine	O
extracolonic	O
manifestations	O
and	O
to	O
investigate	O
the	O
incidence	O
of	O
APC	B
mutations	O
in	O
non	O
-	O
FAP	O
colorectal	B
cancer	I
.	O
	
It	O
is	O
believed	O
that	O
the	O
mutated	O
allele	O
of	O
PAX6	O
produces	O
an	O
inactive	O
protein	O
and	O
aniridia	B
is	O
caused	O
due	O
to	O
genetic	O
haploinsufficiency	O
.	O
	
The	O
common	O
mutation	O
at	O
codon	O
95	O
in	O
exon	O
4	O
might	O
be	O
responsible	O
for	O
most	O
Japanese	O
C9	B
deficiency	I
.	O
.	O
	
In	O
all	O
AAPC	B
kindreds	O
,	O
a	O
predominance	O
of	O
right	O
-	O
sided	O
colorectal	B
adenomas	I
and	O
rectal	B
polyp	I
sparing	O
was	O
observed	O
.	O
	
In	O
a	O
survey	O
of	O
DM	B
in	O
Northern	O
Ireland	O
,	O
59	O
pedigrees	O
were	O
ascertained	O
.	O
	
To	O
identify	O
founder	O
effects	O
,	O
we	O
examined	O
independently	O
ascertained	O
French	O
Canadian	O
cancer	B
families	O
for	O
the	O
distribution	O
of	O
these	O
eight	O
mutations	O
.	O
	
In	O
order	O
to	O
define	O
the	O
types	O
of	O
disease	O
-	O
causing	O
ATM	O
mutations	O
in	O
Japanese	O
A	B
-	I
T	I
patients	O
as	O
well	O
as	O
to	O
look	O
for	O
possible	O
mutational	O
hotspots	O
,	O
reverse	O
-	O
transcribed	O
RNA	O
derived	O
from	O
ten	O
patients	O
belonging	O
to	O
eight	O
unrelated	O
Japanese	O
A	B
-	I
T	I
families	O
was	O
analyzed	O
for	O
mutations	O
by	O
the	O
restriction	O
endonuclease	O
fingerprinting	O
method	O
.	O
	
In	O
approximately	O
5	O
-	O
12	O
%	O
of	O
these	O
cases	O
,	O
there	O
are	O
no	O
demonstrable	O
cardiac	O
or	O
non	O
-	O
cardiac	O
causes	O
to	O
account	O
for	O
the	O
episode	O
,	O
which	O
is	O
therefore	O
classified	O
as	O
idiopathic	B
ventricular	I
fibrillation	I
(	O
IVF	B
)	O
.	O
	
It	O
is	O
crucial	O
to	O
diagnose	O
hemochromatosis	B
before	O
hepatic	B
cirrhosis	I
develops	O
because	O
phlebotomy	O
therapy	O
can	O
avert	O
serious	O
chronic	O
disease	O
and	O
can	O
even	O
lead	O
to	O
normal	O
life	O
expectancy	O
.	O
.	O
	
Mutations	O
of	O
the	O
ATM	O
gene	O
detected	O
in	O
Japanese	O
ataxia	B
-	I
telangiectasia	I
patients	O
:	O
possible	O
preponderance	O
of	O
the	O
two	O
founder	O
mutations	O
4612del165	O
and	O
7883del5	O
.	O
	
Prevalence	O
of	O
the	O
I1307K	O
APC	B
gene	O
variant	O
in	O
Israeli	O
Jews	O
of	O
differing	O
ethnic	O
origin	O
and	O
risk	O
for	O
colorectal	B
cancer	I
.	O
	
Ataxia	B
-	I
telangiectasia	I
(	O
A	B
-	I
T	I
)	O
is	O
a	O
recessive	B
multi	I
-	I
system	I
disorder	I
caused	O
by	O
mutations	O
in	O
the	O
ATM	O
gene	O
at	O
11q22	O
-	O
q23	O
(	O
ref	O
.	O
3	O
)	O
.	O
	
Based	O
on	O
its	O
chromosomal	O
position	O
,	O
this	O
gene	O
is	O
a	O
candidate	O
for	O
conferring	O
susceptibility	O
to	O
diabetes	B
.	O
	
Constitutional	O
RB1	O
-	O
gene	O
mutations	O
in	O
patients	O
with	O
isolated	O
unilateral	B
retinoblastoma	I
.	O
	
The	O
haptoglobin	O
-	O
gene	O
deletion	O
responsible	O
for	O
anhaptoglobinemia	B
.	O
	
In	O
ataxia	B
-	I
telangiectasia	I
(	O
A	B
-	I
T	I
)	O
patients	O
,	O
mutations	O
in	O
a	O
single	O
gene	O
,	O
ATM	O
,	O
result	O
in	O
an	O
autosomal	B
recessive	I
syndrome	I
that	O
embraces	O
a	O
variety	O
of	O
clinical	O
features	O
and	O
manifests	O
extreme	O
radiosensitivity	O
and	O
a	O
strong	O
pre	O
-	O
disposition	O
to	O
malignancy	B
.	O
	
To	O
discover	O
genes	O
involved	O
in	O
von	B
Hippel	I
-	I
Lindau	I
(	O
VHL	B
)	O
-	O
mediated	O
carcinogenesis	O
,	O
we	O
used	O
renal	B
cell	I
carcinoma	I
cell	O
lines	O
stably	O
transfected	O
with	O
wild	O
-	O
type	O
VHL	O
-	O
expressing	O
transgenes	O
.	O
	
Genotype	O
-	O
phenotype	O
correlations	O
in	O
attenuated	B
adenomatous	I
polyposis	I
coli	I
.	O
	
The	O
RB1	O
gene	O
mutation	O
was	O
investigated	O
in	O
a	O
child	O
with	O
ectopic	B
intracranial	I
retinoblastoma	I
using	O
DNA	O
obtained	O
from	O
both	O
the	O
pineal	B
and	I
retinal	I
tumours	I
of	O
the	O
patient	O
.	O
	
Analysis	O
of	O
all	O
family	O
members	O
demonstrated	O
that	O
the	O
missense	O
mutation	O
co	O
-	O
segregated	O
with	O
patients	O
with	O
tumors	B
or	O
who	O
,	O
as	O
a	O
result	O
of	O
linkage	O
analysis	O
had	O
been	O
predicted	O
to	O
carry	O
the	O
predisposing	O
mutation	O
.	O
	
The	O
patient	O
(	O
J	O
.	O
B	O
.	O
)	O
,	O
a	O
17	O
-	O
year	O
-	O
old	O
white	O
male	O
with	O
PWS	B
,	O
was	O
found	O
to	O
have	O
47	O
chromosomes	O
with	O
a	O
supernumerary	O
,	O
paternal	O
der	O
(	O
15	O
)	O
consisting	O
of	O
the	O
short	O
arm	O
and	O
the	O
proximal	O
long	O
arm	O
of	O
chromosome	O
15	O
,	O
and	O
distal	O
chromosome	O
arm	O
3p	O
.	O
	
We	O
conclude	O
that	O
the	O
1422	O
G	O
-	O
-	O
>	O
C	O
mutation	O
is	O
the	O
cause	O
of	O
Hex	B
A	I
enzyme	I
deficiency	I
in	O
the	O
proband	O
.	O
	
One	O
model	O
of	O
DM	B
pathogenesis	O
suggests	O
that	O
RNAs	O
from	O
the	O
expanded	O
allele	O
create	O
a	O
gain	O
-	O
of	O
-	O
function	O
mutation	O
by	O
the	O
inappropriate	O
binding	O
of	O
proteins	O
to	O
the	O
CUG	O
repeats	O
.	O
	
We	O
conclude	O
that	O
the	O
APC	O
I1307K	O
variant	O
leads	O
to	O
increased	O
adenoma	B
formation	O
and	O
directly	O
contributes	O
to	O
3	O
%	O
-	O
4	O
%	O
of	O
all	O
Ashkenazi	O
Jewish	O
colorectal	B
cancer	I
.	O
	
The	O
hypothesis	O
that	O
SWS	B
and	O
SJS	B
type	I
2	I
are	O
the	O
same	O
disorder	O
should	O
be	O
testable	O
by	O
molecular	O
methods	O
.	O
.	O
	
Further	O
evidence	O
for	O
a	O
major	O
ancient	O
mutation	O
underlying	O
myotonic	B
dystrophy	I
from	O
linkage	O
disequilibrium	O
studies	O
in	O
the	O
Japanese	O
population	O
.	O
	
The	O
chromosomal	O
order	O
of	O
genes	O
controlling	O
the	O
major	O
histocompatibility	O
complex	O
,	O
properdin	O
factor	O
B	O
,	O
and	O
deficiency	B
of	I
the	I
second	I
component	I
of	I
complement	I
.	O
	
The	O
genomic	O
structure	O
was	O
determined	O
using	O
DNA	O
from	O
several	O
sources	O
including	O
multiple	O
large	O
-	O
insert	O
libaries	O
and	O
genomic	O
DNA	O
from	O
Finnish	O
CLD	B
patients	O
and	O
controls	O
.	O
	
Here	O
we	O
present	O
four	O
novel	O
PAX6	O
missense	O
mutations	O
,	O
two	O
in	O
association	O
with	O
atypical	O
phenotypes	O
ectopia	B
pupillae	I
(	O
displaced	B
pupils	I
)	O
and	O
congenital	B
nystagmus	I
(	O
searching	B
gaze	I
)	O
,	O
and	O
two	O
in	O
association	O
with	O
more	O
recognizable	O
aniridia	B
phenotypes	O
.	O
	
In	O
this	O
study	O
,	O
we	O
analyzed	O
two	O
families	O
with	O
FNDI	B
using	O
direct	O
automated	O
fluorescent	O
,	O
solid	O
phase	O
,	O
single	O
-	O
stranded	O
DNA	O
sequencing	O
of	O
PCR	O
-	O
amplified	O
AVP	O
-	O
NPII	O
DNA	O
.	O
	
Deficiency	B
of	I
the	I
ninth	I
component	I
of	I
human	I
complement	I
(	O
C9	O
)	O
is	O
the	O
most	O
common	O
complement	B
deficiency	I
in	O
Japan	O
but	O
is	O
rare	O
in	O
other	O
countries	O
.	O
	
Defective	O
thrombosis	B
in	O
mutant	O
mice	O
was	O
also	O
evident	O
in	O
an	O
in	O
vivo	O
model	O
of	O
vascular	B
injury	I
.	O
	
Myotonic	B
dystrophy	I
protein	O
kinase	O
is	O
involved	O
in	O
the	O
modulation	O
of	O
the	O
Ca2	O
+	O
homeostasis	O
in	O
skeletal	O
muscle	O
cells	O
.	O
	
RESULTS	O
In	O
persons	O
at	O
average	O
risk	O
for	O
colorectal	B
cancer	I
,	O
I1307K	O
was	O
found	O
in	O
5	O
.	O
	
No	O
WT1	O
mutations	O
were	O
detected	O
in	O
the	O
six	O
other	O
IDMS	B
patients	O
,	O
suggesting	O
genetic	O
heterogeneity	O
of	O
this	O
disease	O
.	O
	
No	O
desmoid	B
tumors	I
were	O
found	O
in	O
these	O
kindreds	O
.	O
	
PTEN	O
mutations	O
were	O
identified	O
in	O
30	O
of	O
37	O
(	O
81	O
%	O
)	O
CD	B
families	O
,	O
including	O
missense	O
and	O
nonsense	O
point	O
mutations	O
,	O
deletions	O
,	O
insertions	O
,	O
a	O
deletion	O
/	O
insertion	O
and	O
splice	O
site	O
mutations	O
.	O
	
The	O
cyclin	O
-	O
dependent	O
kinase	O
inhibitor	O
,	O
p27	O
,	O
accumulates	O
upon	O
serum	O
withdrawal	O
,	O
only	O
in	O
the	O
presence	O
of	O
VHL	B
,	O
as	O
a	O
result	O
of	O
the	O
stabilization	O
of	O
the	O
protein	O
.	O
	
Paternal	O
transmission	O
of	O
congenital	B
myotonic	I
dystrophy	I
.	O
	
BRCA1	O
and	O
BRCA2	O
account	O
for	O
most	O
cases	O
of	O
familial	O
,	O
early	O
onset	O
breast	B
and	I
/	I
or	I
ovarian	I
cancer	I
and	O
encode	O
products	O
that	O
each	O
interact	O
with	O
hRAD51	O
.	O
	
Mutation	O
A464V	O
was	O
not	O
found	O
in	O
18	O
unrelated	O
MLD	B
patients	O
and	O
50	O
controls	O
.	O
	
The	O
von	B
Hippel	I
-	I
Lindau	I
tumor	I
suppressor	O
gene	O
is	O
required	O
for	O
cell	O
cycle	O
exit	O
upon	O
serum	O
withdrawal	O
.	O
	
A	O
genome	O
-	O
wide	O
search	O
for	O
chromosomal	O
loci	O
linked	O
to	O
mental	O
health	O
wellness	O
in	O
relatives	O
at	O
high	O
risk	O
for	O
bipolar	B
affective	I
disorder	I
among	O
the	O
Old	O
Order	O
Amish	O
.	O
	
Myotonic	B
dystrophy	I
(	O
DM	B
)	O
is	O
an	O
autosomal	B
dominant	I
disease	I
which	O
,	O
in	O
the	O
typical	O
pedigree	O
,	O
shows	O
a	O
three	O
generation	O
anticipation	O
cascade	O
.	O
	
The	O
hemochromatosis	B
gene	O
,	O
HFE	O
,	O
recently	O
has	O
been	O
identified	O
,	O
and	O
characterization	O
of	O
this	O
gene	O
has	O
shown	O
that	O
it	O
contains	O
two	O
mutations	O
that	O
result	O
in	O
amino	O
acid	O
substitutions	O
-	O
cDNA	O
nucleotides	O
845	O
G	O
-	O
-	O
>	O
A	O
(	O
C282Y	O
)	O
and	O
187	O
C	O
-	O
-	O
>	O
G	O
(	O
H63D	O
)	O
.	O
	
These	O
findings	O
represent	O
the	O
first	O
examples	O
of	O
a	O
genetic	B
defect	I
within	O
the	O
POMC	O
gene	O
and	O
define	O
a	O
new	O
monogenic	B
endocrine	I
disorder	I
resulting	O
in	O
early	O
-	O
onset	O
obesity	B
,	O
adrenal	B
insufficiency	I
and	O
red	O
hair	O
pigmentation	O
.	O
.	O
	
HFE	O
is	O
an	O
MHC	O
-	O
related	O
protein	O
that	O
is	O
mutated	O
in	O
the	O
iron	B
-	I
overload	I
disease	I
hereditary	B
hemochromatosis	I
.	O
	
Patients	O
reported	O
as	O
having	O
either	O
neonatal	O
SJS	B
or	O
SWS	B
presented	O
a	O
combination	O
of	O
a	O
severe	O
,	O
prenatal	O
-	O
onset	O
neuromuscular	B
disorder	I
(	O
with	O
congenital	B
joint	I
contractures	I
,	O
respiratory	O
and	O
feeding	O
difficulties	O
,	O
tendency	O
to	O
hyperthermia	B
,	O
and	O
frequent	O
death	O
in	O
infancy	O
)	O
with	O
a	O
distinct	O
campomelic	B
-	I
metaphyseal	I
skeletal	I
dysplasia	I
.	O
	
3x	O
greater	O
if	O
there	O
were	O
at	O
least	O
five	O
cases	O
of	O
breast	B
cancer	I
in	O
the	O
family	O
.	O
	
On	O
the	O
basis	O
of	O
the	O
present	O
study	O
,	O
the	O
mechanism	O
of	O
anhaptoglobinemia	B
and	O
the	O
mechanism	O
of	O
anomalous	O
inheritance	O
of	O
Hp	O
phenotypes	O
were	O
well	O
explained	O
.	O
	
These	O
reagents	O
detect	O
a	O
220	O
-	O
kD	O
protein	O
localized	O
in	O
discrete	O
nuclear	O
foci	O
in	O
all	O
epithelial	O
cell	O
lines	O
,	O
including	O
those	O
derived	O
from	O
breast	B
malignancies	I
.	O
	
The	O
inactivation	O
of	O
the	O
von	B
Hippel	I
-	I
Lindau	I
(	I
VHL	I
)	I
tumor	I
suppressor	O
gene	O
predisposes	O
affected	O
individuals	O
to	O
the	O
human	O
VHL	B
cancer	I
syndrome	I
and	O
is	O
associated	O
with	O
sporadic	B
renal	I
cell	I
carcinomas	I
(	O
RCC	B
)	O
and	O
brain	B
hemangioblastomas	I
.	O
	
To	O
evaluate	O
the	O
role	O
of	O
I1307K	O
in	O
cancer	B
,	O
we	O
genotyped	O
5	O
,	O
081	O
Ashkenazi	O
volunteers	O
in	O
a	O
community	O
survey	O
.	O
	
Occasional	O
missense	O
mutations	O
in	O
ATM	O
were	O
also	O
found	O
in	O
tumour	B
DNA	O
from	O
patients	O
with	O
B	B
-	I
cell	I
non	I
-	I
Hodgkins	I
lymphomas	I
(	O
B	B
-	I
NHL	I
)	O
and	O
a	O
B	B
-	I
NHL	I
cell	O
line	O
.	O
	
Congenital	B
chloride	I
diarrhea	I
(	O
CLD	B
)	O
is	O
caused	O
by	O
mutations	O
in	O
a	O
gene	O
which	O
encodes	O
an	O
intestinal	O
anion	O
transporter	O
.	O
	
The	O
extraordinary	O
conservation	O
of	O
the	O
PAX6	O
protein	O
at	O
the	O
amino	O
acid	O
level	O
amongst	O
vertebrates	O
predicts	O
that	O
pathological	O
missense	O
mutations	O
should	O
in	O
fact	O
be	O
common	O
even	O
though	O
they	O
are	O
hardly	O
ever	O
seen	O
in	O
aniridia	B
patients	O
.	O
	
Human	O
MLH1	O
deficiency	O
predisposes	O
to	O
hematological	B
malignancy	I
and	O
neurofibromatosis	B
type	I
1	I
.	O
	
Germ	O
-	O
line	O
and	O
somatic	O
truncating	O
mutations	O
of	O
the	O
APC	B
gene	O
are	O
thought	O
to	O
initiate	O
colorectal	B
tumor	I
formation	O
in	O
familial	B
adenomatous	I
polyposis	I
syndrome	I
and	O
sporadic	O
colorectal	O
carcinogenesis	O
,	O
respectively	O
.	O
	
Pendred	B
syndrome	I
is	O
an	O
autosomal	B
recessive	I
disorder	I
characterized	O
by	O
early	O
childhood	O
deafness	B
and	O
goiter	B
.	O
	
The	O
clinical	O
diagnosis	O
of	O
AGU	B
is	O
often	O
difficult	O
,	O
in	O
particular	O
early	O
in	O
the	O
course	O
of	O
the	O
disease	O
,	O
and	O
most	O
of	O
the	O
patients	O
are	O
diagnosed	O
after	O
the	O
age	O
of	O
5	O
years	O
.	O
	
Aspartylglucosaminuria	B
among	O
Palestinian	O
Arabs	O
.	O
	
Constitutional	O
mutations	O
of	O
the	O
WT1	O
gene	O
,	O
encoding	O
a	O
zinc	O
-	O
finger	O
transcription	O
factor	O
involved	O
in	O
renal	O
and	O
gonadal	O
development	O
,	O
are	O
found	O
in	O
most	O
patients	O
with	O
Denys	B
-	I
Drash	I
syndrome	I
(	O
DDS	B
)	O
,	O
or	O
diffuse	B
mesangial	I
sclerosis	I
(	O
DMS	B
)	O
associated	O
with	O
pseudohermaphroditism	B
and	O
/	O
or	O
Wilms	B
tumor	I
(	O
WT	B
)	O
.	O
	
Risk	O
reversals	O
in	O
predictive	O
testing	O
for	O
Huntington	B
disease	I
.	O
	
Of	O
clinical	O
interest	O
are	O
(	O
a	O
)	O
the	O
documentation	O
of	O
membranous	O
glomerulonephritis	B
,	O
vasculitis	B
,	O
and	O
arthritis	B
in	O
an	O
individual	O
lacking	O
C5	O
(	O
and	O
its	O
biologic	O
functions	O
)	O
,	O
and	O
(	O
b	O
)	O
a	O
remarkable	O
propensity	O
to	O
bacterial	B
infections	I
in	O
the	O
proband	O
,	O
even	O
during	O
periods	O
of	O
low	O
-	O
dose	O
or	O
alternate	O
-	O
day	O
corticosteroid	O
therapy	O
.	O
	
We	O
report	O
WT1	O
heterozygous	O
mutations	O
in	O
16	O
patients	O
,	O
4	O
of	O
whom	O
presented	O
with	O
IDMS	B
.	O
	
Sporadic	B
prostate	I
carcinoma	I
is	O
the	O
most	O
common	O
male	B
cancer	I
in	O
the	O
Western	O
world	O
,	O
yet	O
many	O
of	O
the	O
major	O
genetic	O
events	O
involved	O
in	O
the	O
progression	O
of	O
this	O
often	O
fatal	O
cancer	B
remain	O
to	O
be	O
elucidated	O
.	O
	
While	O
very	O
few	O
patients	O
with	O
AGU	B
have	O
been	O
reported	O
from	O
non	O
-	O
Finnish	O
origin	O
,	O
we	O
diagnosed	O
the	O
disorder	O
in	O
8	O
patients	O
originating	O
from	O
3	O
unrelated	O
families	O
,	O
all	O
Palestinian	O
Arabs	O
from	O
the	O
region	O
of	O
Jerusalem	O
.	O
	
We	O
report	O
here	O
the	O
identification	O
of	O
a	O
unique	O
de	O
novo	O
L1	O
insertion	O
in	O
the	O
muscle	O
exon	O
1	O
in	O
DMD	O
in	O
three	O
XLDCM	B
patients	O
from	O
two	O
unrelated	O
Japanese	O
families	O
.	O
	
Of	O
57	O
informative	O
meioses	O
,	O
two	O
crossovers	O
were	O
noted	O
between	O
the	O
C2	B
deficiency	I
gene	O
and	O
the	O
HLA	O
-	O
B	O
gene	O
,	O
with	O
a	O
recombinant	O
fraction	O
of	O
0	O
.	O
	
We	O
performed	O
mutation	O
analysis	O
of	O
the	O
PDS	B
gene	O
in	O
patients	O
from	O
14	O
Pendred	B
families	O
originating	O
from	O
seven	O
countries	O
and	O
identified	O
all	O
mutations	O
.	O
	
With	O
direct	O
tests	O
for	O
the	O
HD	B
mutation	O
,	O
we	O
have	O
assessed	O
the	O
accuracy	O
of	O
results	O
obtained	O
by	O
linkage	O
approaches	O
when	O
requested	O
to	O
do	O
so	O
by	O
the	O
test	O
individuals	O
.	O
	
We	O
also	O
show	O
that	O
25	O
%	O
of	O
all	O
A	B
-	I
T	I
patients	O
carried	O
in	O
-	O
frame	O
deletions	O
or	O
missense	O
mutations	O
,	O
many	O
of	O
which	O
were	O
also	O
associated	O
with	O
expression	O
of	O
mutant	O
ATM	O
protein	O
.	O
	
Three	O
novel	O
missense	O
mutations	O
never	O
identified	O
previously	O
in	O
other	O
populations	O
and	O
found	O
in	O
16	O
out	O
of	O
19	O
Colombian	O
MPS	B
IVA	I
unrelated	O
alleles	O
account	O
for	O
84	O
.	O
	
In	O
contrast	O
,	O
no	O
mutations	O
were	O
detected	O
in	O
the	O
p53	O
gene	O
,	O
suggesting	O
that	O
this	O
tumour	B
suppressor	O
is	O
not	O
frequently	O
altered	O
in	O
this	O
leukaemia	B
.	O
	
The	O
evidence	O
of	O
a	O
significant	O
proportion	O
of	O
loss	O
-	O
of	O
-	O
function	O
mutations	O
and	O
a	O
complete	O
absence	O
of	O
the	O
normal	O
copy	O
of	O
ATM	O
in	O
the	O
majority	O
of	O
mutated	O
tumours	B
establishes	O
somatic	O
inactivation	O
of	O
this	O
gene	O
in	O
the	O
pathogenesis	O
of	O
sporadic	B
T	I
-	I
PLL	I
and	O
suggests	O
that	O
ATM	O
acts	O
as	O
a	O
tumour	B
suppressor	O
.	O
	
Heterozygous	O
mutations	O
in	O
the	O
human	O
PAX6	O
gene	O
result	O
in	O
various	O
phenotypes	O
,	O
including	O
aniridia	B
,	O
Peters	B
anomaly	I
,	O
autosomal	B
dominant	I
keratitis	I
,	O
and	O
familial	B
foveal	I
dysplasia	I
.	O
	
These	O
data	O
provide	O
further	O
evidence	O
for	O
extensive	O
allelic	O
heterogeneity	O
in	O
MPS	B
IVA	I
in	O
British	O
-	O
Irish	O
patients	O
and	O
provide	O
evidence	O
for	O
their	O
transmission	O
to	O
Australia	O
by	O
British	O
-	O
Irish	O
migrants	O
.	O
.	O
	
Recent	O
studies	O
in	O
animal	O
models	O
elucidated	O
a	O
central	O
role	O
of	O
alpha	O
-	O
MSH	O
in	O
the	O
regulation	O
of	O
food	O
intake	O
by	O
activation	O
of	O
the	O
brain	O
melanocortin	O
-	O
4	O
-	O
receptor	O
(	O
MC4	O
-	O
R	O
;	O
refs	O
3	O
-	O
5	O
)	O
and	O
the	O
linkage	O
of	O
human	O
obesity	B
to	O
chromosome	O
2	O
in	O
close	O
proximity	O
to	O
the	O
POMC	O
locus	O
,	O
led	O
to	O
the	O
proposal	O
of	O
an	O
association	O
of	O
POMC	O
with	O
human	O
obesity	B
.	O
	
Families	O
were	O
included	O
without	O
regard	O
to	O
the	O
occurrence	O
of	O
ovarian	B
or	I
other	I
cancers	I
.	O
	
Conversely	O
,	O
BRCA1	O
expression	O
was	O
reduced	O
or	O
undetectable	O
in	O
the	O
majority	O
of	O
high	O
-	O
grade	O
,	O
ductal	B
carcinomas	I
,	O
suggesting	O
that	O
absence	O
of	O
BRCA1	O
may	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
a	O
significant	O
percentage	O
of	O
sporadic	B
breast	I
cancers	I
.	O
.	O
	
These	O
results	O
would	O
not	O
be	O
expected	O
if	O
immunostaining	O
at	O
intercalated	O
discs	O
were	O
due	O
to	O
a	O
product	O
of	O
the	O
emerin	O
gene	O
and	O
,	O
therefore	O
,	O
cast	O
some	O
doubt	O
upon	O
the	O
hypothesis	O
that	O
cardiac	B
defects	I
in	O
EDMD	B
are	O
caused	O
by	O
absence	O
of	O
emerin	O
from	O
intercalated	O
discs	O
.	O
	
This	O
results	O
in	O
infertility	B
and	O
congenital	B
myotonic	I
dystrophy	I
(	O
CDM	B
)	O
with	O
the	O
disappearance	O
of	O
DM	B
in	O
that	O
pedigree	O
.	O
	
Biochemical	O
studies	O
indicated	O
VLCAD	B
deficiency	I
caused	O
by	O
a	O
stable	O
yet	O
inactive	O
enzyme	O
.	O
	
His	O
brain	O
magnetic	O
resonance	O
image	O
(	O
MRI	O
)	O
showed	O
abnormalities	B
in	I
the	I
bilateral	I
cerebellar	I
hemispheres	I
and	O
brain	O
stem	O
,	O
but	O
not	O
in	O
the	O
cerebral	O
white	O
matter	O
,	O
where	O
marked	O
reductions	O
of	O
the	O
cerebral	O
blood	O
flow	O
and	O
oxygen	O
metabolism	O
were	O
clearly	O
demonstrated	O
by	O
positron	O
emission	O
tomography	O
(	O
PET	O
)	O
.	O
	
We	O
report	O
on	O
an	O
unusual	O
case	O
of	O
maternal	B
disomy	I
15	I
in	O
PWS	B
that	O
is	O
most	O
consistent	O
with	O
adjacent	O
-	O
1	O
segregation	O
of	O
a	O
paternal	O
t	O
(	O
3	O
;	O
15	O
)	O
(	O
p25	O
;	O
q11	O
.	O
2	O
)	O
with	O
simultaneous	O
maternal	O
meiotic	O
nondisjunction	O
for	O
chromosome	O
15	O
.	O
	
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
genotype	O
-	O
phenotype	O
correlations	O
in	O
AAPC	B
families	O
.	O
	
This	O
should	O
help	O
in	O
the	O
design	O
of	O
tailored	O
clinical	O
-	O
management	O
protocols	O
in	O
this	O
subset	O
of	O
FAP	B
patients	O
.	O
.	O
	
Thus	O
,	O
the	O
occurrence	O
of	O
sensorineural	B
deafness	I
in	O
this	O
patient	O
extends	O
considerably	O
the	O
phenotypic	O
range	O
of	O
piebaldism	B
due	O
to	O
KIT	O
gene	O
mutation	O
in	O
humans	O
and	O
tightens	O
the	O
clinical	O
similarity	O
between	O
piebaldism	B
and	O
the	O
various	O
forms	O
of	O
Waardenburg	B
syndrome	I
.	O
.	O
	
Somatic	O
PTEN	O
deletions	O
and	O
mutations	O
were	O
observed	O
in	O
sporadic	B
breast	I
,	I
brain	I
,	I
prostate	I
and	I
kidney	I
cancer	I
cell	O
lines	O
and	O
in	O
several	O
primary	O
tumours	B
such	O
as	O
endometrial	B
carcinomas	I
,	O
malignant	B
melanoma	I
and	O
thyroid	B
tumours	I
.	O
	
Meningococcal	B
disease	I
is	O
endemic	O
in	O
the	O
Cape	O
and	O
almost	O
all	O
pedigrees	O
of	O
total	O
C6	B
deficiency	I
(	O
C6Q0	O
)	O
have	O
been	O
ascertained	O
because	O
of	O
recurrent	O
disease	O
.	O
	
To	O
characterize	O
the	O
mutational	O
spectrum	O
in	O
various	O
ethnic	O
groups	O
,	O
mutations	O
in	O
the	O
GALNS	O
gene	O
in	O
Colombian	O
MPS	B
IVA	I
patients	O
were	O
investigated	O
,	O
and	O
genetic	O
backgrounds	O
were	O
extensively	O
analyzed	O
to	O
identify	O
racial	O
origin	O
,	O
based	O
on	O
mitochondrial	O
DNA	O
(	O
mtDNA	O
)	O
lineages	O
.	O
	
Angelman	B
syndrome	I
(	O
AS	B
)	O
is	O
caused	O
by	O
chromosome	O
15q11	O
-	O
q13	O
deletions	O
of	O
maternal	O
origin	O
,	O
by	O
paternal	O
uniparental	B
disomy	I
(	O
UPD	B
)	O
15	O
,	O
by	O
imprinting	O
defects	O
,	O
and	O
by	O
mutations	O
in	O
the	O
UBE3A	O
gene	O
.	O
	
Sibships	O
where	O
the	O
status	O
of	O
all	O
the	O
members	O
had	O
been	O
identified	O
were	O
examined	O
to	O
determine	O
the	O
transmission	O
of	O
the	O
DM	B
expansion	O
from	O
affected	O
parents	O
to	O
their	O
offspring	O
.	O
	
Coincidence	O
of	O
two	O
novel	O
arylsulfatase	O
A	O
alleles	O
and	O
mutation	O
459	O
+	O
1G	O
>	O
A	O
within	O
a	O
family	O
with	O
metachromatic	B
leukodystrophy	I
:	O
molecular	O
basis	O
of	O
phenotypic	O
heterogeneity	O
.	O
	
Although	O
the	O
link	O
between	O
the	O
BRCA1	O
tumour	B
-	O
suppressor	O
gene	O
and	O
hereditary	B
breast	I
and	I
ovarian	I
cancer	I
is	O
established	O
,	O
the	O
role	O
,	O
if	O
any	O
,	O
of	O
BRCA1	O
in	O
non	B
-	I
familial	I
cancers	I
is	O
unclear	O
.	O
	
This	O
disorder	O
is	O
reminiscent	O
of	O
another	O
rare	O
condition	O
,	O
the	O
Stuve	B
-	I
Wiedemann	I
syndrome	I
(	O
SWS	B
)	O
,	O
which	O
comprises	O
campomelia	B
at	O
birth	O
with	O
skeletal	B
dysplasia	I
,	O
contractures	B
,	O
and	O
early	B
death	I
.	O
	
The	O
estimated	O
cumulative	O
risk	O
of	O
breast	B
cancer	I
reached	O
28	O
%	O
(	O
95	O
%	O
CI	O
9	O
%	O
-	O
44	O
%	O
)	O
by	O
age	O
50	O
years	O
and	O
84	O
%	O
(	O
95	O
%	O
CI	O
43	O
%	O
-	O
95	O
%	O
)	O
by	O
age	O
70	O
years	O
.	O
	
The	O
first	O
predictive	O
testing	O
for	O
Huntington	B
disease	I
(	O
HD	B
)	O
was	O
based	O
on	O
analysis	O
of	O
linked	O
polymorphic	O
DNA	O
markers	O
to	O
estimate	O
the	O
likelihood	O
of	O
inheriting	O
the	O
mutation	O
for	O
HD	B
.	O
	
No	O
locus	O
other	O
than	O
chromosome	O
11p13	O
has	O
been	O
implicated	O
in	O
aniridia	B
,	O
and	O
PAX6	O
is	O
clearly	O
the	O
major	O
,	O
if	O
not	O
only	O
,	O
gene	O
responsible	O
.	O
	
BACKGROUND	O
Women	O
with	O
mutations	O
in	O
either	O
the	O
BRCA1	O
or	O
the	O
BRCA2	O
gene	O
have	O
a	O
high	O
lifetime	O
risk	O
of	O
ovarian	B
cancer	I
.	O
	
A	O
hot	O
spot	O
for	O
PTEN	O
mutation	O
in	O
CD	B
was	O
identified	O
in	O
exon	O
5	O
that	O
contains	O
the	O
PTPase	O
core	O
motif	O
,	O
with	O
13	O
of	O
30	O
(	O
43	O
%	O
)	O
CD	B
mutations	O
identified	O
in	O
this	O
exon	O
.	O
	
The	O
most	O
common	O
phenotypic	O
features	O
,	O
present	O
in	O
more	O
than	O
a	O
third	O
of	O
our	O
patients	O
with	O
TWIST	O
mutations	O
,	O
are	O
coronal	B
synostosis	I
,	O
brachycephaly	B
,	O
low	B
frontal	I
hairline	I
,	O
facial	B
asymmetry	I
,	O
ptosis	B
,	O
hypertelorism	B
,	O
broad	B
great	I
toes	I
,	O
and	O
clinodactyly	B
.	O
	
METHODS	O
Twins	O
with	O
AS	B
were	O
identified	O
from	O
the	O
Royal	O
National	O
Hospital	O
for	O
Rheumatic	B
Diseases	I
database	O
.	O
	
Classical	O
familial	B
adenomatous	I
polyposis	I
(	O
FAP	B
)	O
is	O
a	O
high	O
-	O
penetrance	O
autosomal	B
dominant	I
disease	I
that	O
predisposes	O
to	O
hundreds	O
or	O
thousands	O
of	O
colorectal	B
adenomas	I
and	I
carcinoma	I
and	O
that	O
results	O
from	O
truncating	O
mutations	O
in	O
the	O
APC	B
gene	O
.	O
	
Mutations	O
were	O
detected	O
in	O
21	O
(	O
91	O
%	O
)	O
of	O
23	O
tumors	B
with	O
LOH	O
.	O
	
187	O
C	O
-	O
-	O
>	O
G	O
was	O
present	O
at	O
an	O
allele	O
frequency	O
of	O
2	O
.	O
	
In	O
patients	O
of	O
Dutch	O
ethnic	O
origin	O
,	O
however	O
,	O
no	O
significant	O
founder	O
effect	O
could	O
be	O
identified	O
.	O
	
The	O
average	O
age	O
of	O
disease	O
onset	O
in	O
those	O
families	O
harbouring	O
causative	O
mutations	O
was	O
between	O
32	O
.	O
	
Although	O
increasing	O
measured	O
allele	O
size	O
between	O
patients	O
clearly	O
correlates	O
with	O
an	O
increased	O
severity	O
of	O
symptoms	O
and	O
an	O
earlier	O
age	O
of	O
onset	O
,	O
this	O
correlation	O
is	O
not	O
precise	O
and	O
measured	O
allele	O
length	O
cannot	O
be	O
used	O
as	O
an	O
accurate	O
predictor	O
of	O
age	O
of	O
onset	O
.	O
	
The	O
initial	O
mutation	O
was	O
shown	O
to	O
have	O
occurred	O
in	O
the	O
paternally	O
derived	O
RB1	O
allele	O
.	O
	
His	O
affected	O
son	O
has	O
repeat	O
sizes	O
of	O
1040	O
and	O
540	O
.	O
	
Results	O
showed	O
that	O
the	O
845	O
G	O
-	O
-	O
>	O
A	O
mutation	O
was	O
present	O
in	O
these	O
populations	O
(	O
allele	O
frequency	O
0	O
.	O
32	O
%	O
)	O
,	O
and	O
,	O
furthermore	O
,	O
it	O
was	O
always	O
seen	O
in	O
conjunction	O
with	O
HLA	O
haplotypes	O
common	O
in	O
Caucasians	O
,	O
suggesting	O
that	O
845	O
G	O
-	O
-	O
>	O
A	O
may	O
have	O
been	O
introduced	O
into	O
these	O
populations	O
by	O
Caucasian	O
admixture	O
.	O
	
The	O
observation	O
of	O
these	O
symptoms	O
in	O
two	O
probands	O
prompted	O
us	O
to	O
search	O
for	O
mutations	O
within	O
their	O
POMC	O
genes	O
.	O
	
Twenty	O
-	O
eight	O
percent	O
of	O
identified	O
PAX6	O
mutations	O
are	O
C	O
-	O
T	O
changes	O
at	O
CpG	O
dinucleotides	O
,	O
20	O
%	O
are	O
splicing	O
errors	O
,	O
and	O
more	O
than	O
30	O
%	O
are	O
deletion	O
or	O
insertion	O
events	O
.	O
	
We	O
also	O
show	O
that	O
in	O
all	O
informative	O
carrier	O
father	O
to	O
affected	O
child	O
transmissions	O
,	O
with	O
the	O
notable	O
exception	O
of	O
the	O
premutation	O
carrier	O
,	O
the	O
expansion	O
size	O
decreases	O
.	O
.	O
	
We	O
have	O
studied	O
the	O
codon	O
282	O
(	O
Cys	O
/	O
Tyr	O
)	O
polymorphism	O
in	O
different	O
ethnic	O
groups	O
.	O
	
Neuropsychological	O
analysis	O
assessed	O
verbal	O
and	O
visuospatial	O
intelligence	O
,	O
verbal	O
memory	O
,	O
and	O
reading	O
skills	O
.	O
	
Sequential	O
cleavage	O
of	O
the	O
precursor	O
protein	O
pre	O
-	O
pro	O
-	O
opiomelanocortin	O
(	O
POMC	O
)	O
generates	O
the	O
melanocortin	O
peptides	O
adrenocorticotrophin	O
(	O
ACTH	O
)	O
,	O
melanocyte	O
-	O
stimulating	O
hormones	O
(	O
MSH	O
)	O
alpha	O
,	O
beta	O
and	O
gamma	O
as	O
well	O
as	O
the	O
opioid	O
-	O
receptor	O
ligand	O
beta	O
-	O
endorphin	O
.	O
	
Interestingly	O
,	O
none	O
of	O
these	O
mutations	O
was	O
observed	O
in	O
the	O
PTPase	O
core	O
motif	O
.	O
	
In	O
1	O
patient	O
,	O
somatic	O
mosaicism	O
was	O
demonstrated	O
by	O
molecular	O
analysis	O
of	O
DNA	O
and	O
RNA	O
from	O
peripheral	O
blood	O
.	O
	
The	O
APC	O
I1307K	O
allele	O
was	O
identified	O
in	O
48	O
(	O
10	O
.	O
1	O
%	O
)	O
of	O
476	O
patients	O
.	O
	
Strikingly	O
,	O
all	O
four	O
mutations	O
are	O
located	O
within	O
the	O
PAX6	O
paired	O
domain	O
and	O
affect	O
amino	O
acids	O
which	O
are	O
highly	O
conserved	O
in	O
all	O
known	O
paired	O
domain	O
proteins	O
.	O
	
PAX6	O
mutations	O
reviewed	O
.	O
	
However	O
,	O
the	O
different	O
allelic	O
pattern	O
at	O
the	O
BRCA1	O
locus	O
even	O
in	O
some	O
Jewish	O
mutation	O
carriers	O
,	O
might	O
suggest	O
that	O
the	O
mutation	O
arose	O
independently	O
.	O
.	O
	
We	O
conclude	O
that	O
the	O
185delAG	O
BRCA1	O
mutation	O
occurs	O
in	O
some	O
non	O
-	O
Ashkenazi	O
populations	O
at	O
rates	O
comparable	O
with	O
that	O
of	O
Ashkenazim	O
.	O
	
